Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Nonviral conversion of skin or blood cells into clinically useful human induced pluripotent stem cells (hiPSC) occurs in only rare fractions (~0.001%-0.5%) of donor cells transfected with non-integrating reprogramming factors. Pluripotency induction of developmentally immature stem-progenitors is generally more efficient than differentiated somatic cell targets. However, the nature of augmented progenitor reprogramming remains obscure, and its potential has not been fully explored for improving the extremely slow pace of non-integrated reprogramming. Here, we report highly optimized four-factor reprogramming of lineage-committed cord blood (CB) myeloid progenitors with bulk efficiencies of ~50% in purified episome-expressing cells. Lineage-committed CD33(+)CD45(+)CD34(-) myeloid cells and not primitive hematopoietic stem-progenitors were the main targets of a rapid and nearly complete non-integrated reprogramming. The efficient conversion of mature myeloid populations into NANOG(+)TRA-1-81(+) hiPSC was mediated by synergies between hematopoietic growth factor (GF), stromal activation signals, and episomal Yamanaka factor expression. Using a modular bioinformatics approach, we demonstrated that efficient myeloid reprogramming correlated not to increased proliferation or endogenous Core factor expressions, but to poised expression of GF-activated transcriptional circuits that commonly regulate plasticity in both hematopoietic progenitors and embryonic stem cells (ESC). Factor-driven conversion of myeloid progenitors to a high-fidelity pluripotent state was further accelerated by soluble and contact-dependent stromal signals that included an implied and unexpected role for Toll receptor-NFκB signaling. These data provide a paradigm for understanding the augmented reprogramming capacity of somatic progenitors, and reveal that efficient induced pluripotency in other cell types may also require extrinsic activation of a molecular framework that commonly regulates self-renewal and differentiation in both hematopoietic progenitors and ESC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 BMSC co-culture primed efficient non-integrated reprogramming of CB progenitors that required only four episomal Yamanaka factors on a single plasmid. The role of a brief 3-day BMSC co-culture of GF-activated CD34+ CB progenitors following a single pulse of episomal plasmids on Day 0, and the number of episomal factors required for efficient reprogramming. The experimental design is summarized in Fig. S1 . (a) Soluble factors from brief BMSC co-culture preserved the viability of GF-activated CB progenitors. Viable CB cells were enumerated via Trypan Blue on Day 3 following nucleofection with four episomal factors (SOX2, OCT4, KLF4, MYC; 4F) on Day 0. Shown are the fold-increases of GF-treated CD34+ CB cells from Day 0 to Day 3 that resulted from: no BMSC co-culture (-BMSC), with irradiated BMSC co-culture (+BMSC), or with BMSC co-culture but separated by a Transwell insert (BMSC (T)). The Transwell culture insert prevented cell-cell contact between BMSC and CB cells, but allowed soluble stromal factors to diffuse freely to the cultured CB cells. Averages, SEM, and p values (Students t test) of n = 4 averaged experiments is shown. NS = not significant (p>0.05). (b) Brief co-culture of GF-activated CB cells with irradiated BMSC (+BMSC) did not increase the frequency of cells in G1 or S cell cycle phases at Day 3 (D3) of the reprogramming protocol (see Fig. S1 ) compared to GF alone (-BMSC). CB cells were nucleofected on Day 0 (D0) with 4F or 7F plasmids, or nucleofected with Amaxa buffer only (Mock). Cell cycle status of stromal-activated D3 CB, DO (pre-nucleofected) control CB cells, and adult fibroblasts (HDF1, HUF5; nucleofected with 7F) was determined on Day 3 of reprogramming protocols via FACS analysis of EdU incorporation and DNA content (7AAD), as described in Methods. Cells in G1 phase were defined as being EdU negative and 7AAD(2n); % cells in S phase were determined by gating on EdU positive 7AAD (2n+) populations. Data shown is the average of 2 experiments from individual batches of pooled CB donors run in triplicate. (c) GF-activated CB cells consist of a relatively homogenous myeloid population. By Day 3 of the reprogramming protocol (following +/− BMSC co-culture), both CD34+ and CD34− GF-activated CD45+ CB progenitors had differentiated to primarily a myeloid CD33+ and CD13+ (not shown) phenotype. (d) Episomal reprogramming efficiencies of various somatic targets with either four factors (4F; SOKM, on a single plasmid, pEP4 EO2S EM2K) or seven factors (7F; SOKMNLT, on three separate plasmids), and with (+) or without (−) BMSC priming were determined by rapid AP staining (in triplicate) at 3 weeks following episomal nucleofections for CB progenitors (CB), fetal fibroblasts (FFB), adult fibroblasts (AdFib), and adult keratinocytes (Ker). Reprogramming efficiencies for emergence of Type III hiPSC [45] were quantitated in some experiments with parallel live TRA-1-81 staining, which gave similar results to enumeration of AP+ hESC-like colonies ( Fig. S3 ). By 3 weeks post 4F nucleofections, the majority of AP+ hESC-like colonies had already converted with extremely high efficiencies to 50–80% fully reprogrammed SSEA4+TRA-1-81+NANOG+ Type III hiPSC (see also Fig. 7a). Each condition presented was repeated at least two to five times, as indicated, and with significance (t test; * = p<0.05) as indicated. 4F SOKM reprogramming of CB progenitors was even more robust than with equimolar DNA quantities of the 7F three-plasmid system (albeit initially less rapid). ND; BMSC co-culture was not done. With omission of the brief BMSC activation step, rarer (∼10–150-fold less) and slower-emerging CB-iPSC were produced with single-plasmid 4F nucleofections, but at frequencies that were still significantly greater than 7F reprogramming of fetal and adult fibroblasts, or adult keratinocytes.](https://figures.cochat.ai/paper-figures/b2db4ab65e8a44c89d088056e74e0ca0/growth-factor-activated-stem-cell-circuits-and-stromal-signals-cooperatively-figure-1.jpg)
![Figure 2 Episomal 4F reprogramming of FACS-purified hematopoietic populations. (a) Schematic summarizes the experimental strategy for determining 4F reprogramming efficiencies of FACS-purified hematopoietic progenitors of (b) BMSC-primed lineage-committed or (c) +/− BMSC-primed transgene-enriched myeloid populations. Experimental details are provided in Materials and Methods. The %CD34+ gradient symbol above the schematic reflects the concept that multipotent primitive CD34+CD38lo stem-progenitors are enriched during Days -3 to -2, but differentiate rapidly in culture thereafter (see also Fig. 1c and Fig. S2a). CD34+CD38lo stem-progenitors give rise to lineage-committed CD34+CD38+ progenitors which subsequently differentiate further to CD34-negative CD33+CD45+ myeloid cells (e.g., promyelocytes). Post-sort analysis of FACS-purified Day 0 CD34+CD38+ CB fractions verified that >95% of this populations consisted of CD33+CD13+CD45+ myeloid cells (see also Fig. 1c). Both reprogramming efficiency (AP and live TRA-1-81 staining of hESC-like colonies) and reprogramming completion (bulk SSEA4+TRA-1-81+ and NANOG+ FACS staining) assays were conducted 4 weeks following 4F nucleofections on P0 MEF cultures. (b) Shown is a representative AP staining (plates done in triplicate, with indicated average number of hESC-like colonies emerging per the number of single sorted day 3 BMSC-primed CB cells plated on MEF (i.e., unsorted CB vs. CD34+CD38lo vs. CD34+CD38+ fractions. The averaged results of two independent experiments are indicated. In lower panels are shown representative FACS staining of surface TRA-1-81 and intracellular NANOG pluripotency markers of the same cultures demonstrating that 50–80% of AP+ hESC-like colonies possessed a Type III TRA-1-81+NANOG+ phenotype [43]. (c) To determine the more accurate reprogramming efficiency of purified +/− BMSC-primed episome-expressing myeloid populations, CB progenitors were co-nucleofected on day 0 with both the 4F pEP4 EO2S EM2K episome, as well as a pCEP4-GFP episomal GFP reporter construct. Episomal transgene expressing-only populations were subsequently FACS-purified by GFP expression prior to plating on day 3 MEF following with (+BMSC) or without (-BMSC) stromal co-culture. This was done by staining +/− BMSC-primed CB cells on day 3 with CD34-PE and FACS-purifying them into episome-expressing (GFP+CD34+, GFP+CD34−), and non episome-expressing (GFP−) populations prior to MEF plating. The results of AP stained plates shown are representative of independent sorting experiments using pooled donor CB samples for each 4F nucleofection, with the averaged results of two independent experiments indicated below. FACS analysis of these same experiments (data not shown) revealed 60% TRA-1-81 and NANOG expression for +BMSC AP+ colonies (GFP+CD34−), and 55% TRA-1-81 expression for –BMSC AP+ colonies (GFP+CD34−).](https://figures.cochat.ai/paper-figures/ef5b299a032b479abaf98f6d39fa82a8/growth-factor-activated-stem-cell-circuits-and-stromal-signals-cooperatively-figure-2.jpg)

![Figure 4 Partially reprogrammed stem cell modules in GF-activated CB myeloid progenitors are rapidly reconfigured to hESC-like patterns. (a) Illumina microarray expressions of ESC-like gene modules (MYC, PRC1, PRC2, and Core; see Table S1 for gene lists). Shown are donor cell populations with (+) and without (−) 4F episomal nucleofections, and with (+) and without (−) BMSC-priming: adult fibroblasts (F), Day -3 unstimulated CB cells (D-3 CB), Day 0 FTK GF-stimulated CB cells (D0), Day 3+/− BMSC-primed (D3), and bulk Day 23 early CB-iPSC culture (D23 iPSC). These early D23 iPSC populations were already composed of >50–60% populations with fully-reprogrammed TRA-1-81+NANOG+ phenotypes. Undifferentiated H9 hESC samples served as control (hESC). Module expressions represent log2 mean-subtracted normalized values of signal intensities from averaged, independent biological replicate microarray samples (n = 3 per condition). Although they possessed a transcriptionally inactive Core module, day 0 GF-activated CB progenitors expressed active ESC and MYC modules, and inactive PRC1, and PRC2 modules at mean expression levels that were already comparable to levels in hESC. The annotation and references of all genes in each module is provided in Table S1. (b) Partially reprogrammed ESC module [26] expression in CB progenitors. Legend for each sample is the same as above. Unsupervised hierarchical clustering heatmaps of (b) expression and (c) Box plots of log2 mean-normalized values of the ESC module gene signal intensities in somatic target populations, hESC, and reprogrammed cell lines. The heatmap’s color scale was chosen to emphasize subtle mid-range change. The resulting values emphasize relative expression across cell types rather than relative absolute expression across genes. This box and whisker plots (right panels) depict the log2 mean-subtracted normalized values of signal intensities of genes comprising the module set for each cell type indicated from Illumina array data. The top and bottom of a box mark the 75th and 25th percentile log2 signal values, respectively, while the bar at the middle denotes the median. The whiskers above and below each box mark the upper 90th and lower 10th percentiles. Paired tests with significance p<0.05 (*) or without significance (NS; p>0.05) with values of control hESC are indicated.](https://figures.cochat.ai/paper-figures/449a236d5b6e4e618d5ec195316fc5f2/growth-factor-activated-stem-cell-circuits-and-stromal-signals-cooperatively-figure-4.jpg)
![Figure 5 GF-activated progenitors expressed an active OCT4-associated network as well as chromatin remodeling factors known to augment iPSC generation. (a) Unsupervised hierarchical clustering heatmap of expression of the OCT4 interactome module [24] (Table S1) in fibroblasts (F), CB progenitors at various stages of the reprogramming protocol (D-3, D0, D3+/− BMSC), day 23 bulk early CB-iPSC cultures (D23 iPSC), and hESC (H9) controls. Gene arrays samples (n = 3 per condition) are the same as defined above. Box and whisker plots of same samples of the log2 mean-subtracted normalized values of signal intensities of gene module sets for (b) a subset of the OCT4 interactome consisting of ESC-regulating epigenetic modulators [24] (see Table S1 for list), (c) the MYC transcription factor complex [27] (N-MYC, C-MYC, E2F4, E2F1, ZFX, MAX), and (d) the PRC2 repressive complex [32] (JARID2, MTF2, EZH2, RBBP4, EPC2, EPC1, SUZ12, EED, EZH1, JARID1A, RBBP7, PHF19, PHF1).](https://figures.cochat.ai/paper-figures/3c771dc69cb446ab94901153515f521b/growth-factor-activated-stem-cell-circuits-and-stromal-signals-cooperatively-figure-5.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CCL5 can be secreted by both BM-MSC and ASC [100, 144] and displays pro-proliferative activities on breast cancer cell lines [145, 146].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [146]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“pluripotency. We determined the expression signatures of these non-integrated hiPSC clones with Illumina microarrays, and also included previously described lentiviral hiPSC lines IMR90-1 and IMR90-2”
MethodA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361 · cited 2×
“, PRC1, PRC2) to silence lineage specification [31–34].”
BackgroundCore Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V. B., Wong, E., Orlov, Y. L., Zhang, W., Jiang, J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.043 · Cited by 2,501
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K.-I., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,268
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt.1502 · Cited by 1,341
An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells
Kim, J., Chu, J., Shen, X., Wang, J., & Orkin, S. H. (2008) · Cell · doi:10.1016/j.cell.2008.02.039 · Cited by 1,332
A protein interaction network for pluripotency of embryonic stem cells
Wang, J., Rao, S., Chu, J., Shen, X., Levasseur, D. N., Theunissen, T. W., & Orkin, S. H. (2006) · Nature · doi:10.1038/nature05284 · Cited by 1,099
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Ku, M., Koche, R. P., Rheinbay, E., Mendenhall, E. M., Endoh, M., Mikkelsen, T. S., Presser, A., Nusbaum, C., Xie, X., Chi, A. S., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000242 · Cited by 1,009
Hyperdynamic Plasticity of Chromatin Proteins in Pluripotent Embryonic Stem Cells
Meshorer, E., Yellajoshula, D., George, E., Scambler, P. J., Brown, D. T., & Misteli, T. (2006) · Developmental Cell · doi:10.1016/j.devcel.2005.10.017 · Cited by 1,008
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors
Kim, J. B., Zaehres, H., Wu, G., Gentile, L., Ko, K., Sebastiano, V., Araúzo-Bravo, M. J., Ruau, D., Han, D. W., Zenke, M., et al. (2008) · Nature · doi:10.1038/nature07061 · Cited by 962
Direct cell reprogramming is a stochastic process amenable to acceleration
Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A., & Jaenisch, R. (2009) · Nature · doi:10.1038/nature08592 · Cited by 938
Oct4-Induced Pluripotency in Adult Neural Stem Cells
Kim, J. B., Sebastiano, V., Wu, G., Araúzo-Bravo, M. J., Sasse, P., Gentile, L., Ko, K., Ruau, D., Ehrich, M., van den Boom, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.023 · Cited by 934
Sequential Expression of Pluripotency Markers during Direct Reprogramming of Mouse Somatic Cells
Brambrink, T., Foreman, R., Welstead, G. G., Lengner, C. J., Wernig, M., Suh, H., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.004 · Cited by 821
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells
Hawkins, R. D., Hon, G. C., Lee, L. K., Ngo, Q., Lister, R., Pelizzola, M., Edsall, L. E., Kuan, S., Luu, Y., Klugman, S., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.018 · Cited by 806
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734 · cited 4×
“However, non-integrated reprogramming of human somatic fibroblasts [1–3] or stemprogenitors is even less efficient (,0.”
BackgroundInfluentialModule Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells
Wong, D. J., Liu, H., Ridky, T. W., Cassarino, D., Segal, E., & Chang, H. Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.02.009 · Cited by 720
Kim, J., Woo, A. J., Chu, J., Snow, J. W., Fujiwara, Y., Kim, C. G., Cantor, A. B., & Orkin, S. H. (2010) · Cell · doi:10.1016/j.cell.2010.09.010 · Cited by 669
Role of the Murine Reprogramming Factors in the Induction of Pluripotency
Sridharan, R., Tchieu, J., Mason, M. J., Yachechko, R., Kuoy, E., Horvath, S., Zhou, Q., & Plath, K. (2009) · Cell · doi:10.1016/j.cell.2009.01.001 · Cited by 643
Cui, K., Zang, C., Roh, T.-Y., Schones, D. E., Childs, R. W., Peng, W., & Zhao, K. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.011 · Cited by 618
Ang, Y.-S., Tsai, S.-Y., Lee, D.-F., Monk, J., Su, J., Ratnakumar, K., Ding, J., Ge, Y., Darr, H., Chang, B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.003 · Cited by 545
An Oct4-Centered Protein Interaction Network in Embryonic Stem Cells
van den Berg, D. L. C., Snoek, T., Mullin, N. P., Yates, A., Bezstarosti, K., Demmers, J., Chambers, I., & Poot, R. A. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.02.014 · Cited by 542
Chd1 regulates open chromatin and pluripotency of embryonic stem cells
Gaspar-Maia, A., Alajem, A., Polesso, F., Sridharan, R., Mason, M. J., Heidersbach, A., Ramalho-Santos, J., McManus, M. T., Plath, K., Meshorer, E., et al. (2009) · Nature · doi:10.1038/nature08212 · Cited by 509
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells
Chan, E. M., Ratanasirintrawoot, S., Park, I.-H., Manos, P. D., Loh, Y.-H., Huo, H., Miller, J. D., Hartung, O., Rho, J., Ince, T. A., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1580 · Cited by 487
Chou, B.-K., Mali, P., Huang, X., Ye, Z., Dowey, S. N., Resar, L. M., Zou, C., Zhang, Y. A., Tong, J., & Cheng, L. (2011) · Cell Research · doi:10.1038/cr.2011.12 · Cited by 484
Eminli, S., Foudi, A., Stadtfeld, M., Maherali, N., Ahfeldt, T., Mostoslavsky, G., Hock, H., & Hochedlinger, K. (2009) · Nature Genetics · doi:10.1038/ng.428 · Cited by 442
Wnt Signaling Promotes Reprogramming of Somatic Cells to Pluripotency
Marson, A., Foreman, R., Chevalier, B., Bilodeau, S., Kahn, M., Young, R. A., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.019 · Cited by 436
A Multi-Agent Approach for Web Adaptation.
Rozkosz, E. A., Siuda, P., Stunża, G. D., Dąbrowska, A. J., Klimowicz, M., Kulczycki, E., Muszyński, D., Piotrowska, R., Sieńko, M., & Stachura, K. (1999) · Electronic Archive of the National University "Odessa Law Academy" (Scientific Library of the Odessa Law Academy) · doi:10.1007/978 · Cited by 423
Burridge, P. W., Thompson, S., Millrod, M. A., Weinberg, S., Yuan, X., Peters, A., Mahairaki, V., Koliatsos, V. E., Tung, L., & Zambidis, E. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018293 · Cited by 417
Self-citationGeneration of Induced Pluripotent Stem Cells from Human Cord Blood Using OCT4 and SOX2
Giorgetti, A., Montserrat, N., Aasen, T., Gonzalez, F., Rodríguez-Pizà, I., Vassena, R., Raya, A., Boué, S., Barrero, M. J., Corbella, B. A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.008 · Cited by 408
An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and Disease
Pardo, M., Lang, B., Yu, L., Prosser, H., Bradley, A., Babu, M. M., & Choudhary, J. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.004 · Cited by 379
Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming
Singhal, N., Graumann, J., Wu, G., Araúzo-Bravo, M. J., Han, D. W., Greber, B., Gentile, L., Mann, M., & Schöler, H. R. (2010) · Cell · doi:10.1016/j.cell.2010.04.037 · Cited by 378 · cited 4×
“, members of the MYC [27], Polycomb (PRC2, PRC1) [31–34], Chromodomain (CHD) [36], SWI/SWF [37], and Trithorax [38] complex families) (Fig.”
BackgroundInfluentialZambidis, E. T., Peault, B., Park, T. S., Bunz, F., & Civin, C. I. (2005) · Blood · doi:10.1182/blood-2004-11-4522 · Cited by 370
Self-citationReprogramming Factor Expression Initiates Widespread Targeted Chromatin Remodeling
Koche, R. P., Smith, Z. D., Adli, M., Gu, H., Ku, M., Gnirke, A., Bernstein, B. E., & Meissner, A. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.001 · Cited by 355
Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming
Lee, J., Sayed, N., Hunter, A., Au, K. F., Wong, W. H., Mocarski, E. S., Pera, R. R., Yakubov, E., & Cooke, J. P. (2012) · Cell · doi:10.1016/j.cell.2012.09.034 · Cited by 344
Hu, K., Yu, J., Suknuntha, K., Tian, S., Montgomery, K., Choi, K.-D., Stewart, R., Thomson, J. A., & Slukvin, I. I. (2011) · Blood · doi:10.1182/blood-2010-07-298331 · Cited by 254
Zfx Controls the Self-Renewal of Embryonic and Hematopoietic Stem Cells
Galan-Caridad, J. M., Harel, S., Arenzana, T. L., Hou, Z. E., Doetsch, F. K., Mirny, L. A., & Reizis, B. (2007) · Cell · doi:10.1016/j.cell.2007.03.014 · Cited by 244
Integrins Regulate Mouse Embryonic Stem Cell Self-Renewal
Hayashi, Y., Furue, M. K., Okamoto, T., Ohnuma, K., Myoishi, Y., Fukuhara, Y., Abe, T., Sato, J. D., Hata, R.-I., & Asashima, M. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0103 · Cited by 219
Chou, Y.-F., Chen, H.-H., Eijpe, M., Yabuuchi, A., Chenoweth, J. G., Tesar, P., Lu, J., McKay, R. D. G., & Geijsen, N. (2008) · Cell · doi:10.1016/j.cell.2008.08.035 · Cited by 204
Zambidis, E. T., Soon Park, T., Yu, W., Tam, A., Levine, M., Yuan, X., Pryzhkova, M., & Péault, B. (2008) · Blood · doi:10.1182/blood-2008-03-144766 · Cited by 196
Self-citationOguro, H., Yuan, J., Ichikawa, H., Ikawa, T., Yamazaki, S., Kawamoto, H., Nakauchi, H., & Iwama, A. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.01.005 · Cited by 185
ESCs Require PRC2 to Direct the Successful Reprogramming of Differentiated Cells toward Pluripotency
Pereira, C. F., Piccolo, F. M., Tsubouchi, T., Sauer, S., Ryan, N. K., Bruno, L., Landeira, D., Santos, J., Banito, A., Gil, J., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.013 · Cited by 168
Oct4 links multiple epigenetic pathways to the pluripotency network
Ding, J., Xu, H., Faiola, F., Ma'ayan, A., & Wang, J. (2012) · Cell Research · doi:10.1038/cr.2011.179 · Cited by 162
Differential H3K4 Methylation Identifies Developmentally Poised Hematopoietic Genes
Orford, K. W., Kharchenko, P. V., Lai, W. R., Dao, M. C., Worhunsky, D. J., Ferro, A., Janzen, V., Park, P. J., & Scadden, D. T. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.04.002 · Cited by 155
Sung, L., Gao, S., Shen, H., Yu, H. M., Song, Y., Marjani, S. L., Chang, C.-C., Inoue, K., Kuo, L., Lian, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1895 · Cited by 129
Murray, L. J., Young, J. C., Osborne, L. J., Luens, K. M., Scollay, R. G., & Hill, B. L. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00031-4 · Cited by 120
Inefficient reprogramming of the hematopoietic stem cell genome following nuclear transfer
Inoue, K., Ogonuki, N., Miki, H., Hirose, M., Noda, S., Kim, J., Aoki, F., Miyoshi, H., & Ogura, A. (2006) · Journal of Cell Science · doi:10.1242/jcs.02913 · Cited by 113
Weishaupt, H., Sigvardsson, M., & Attema, J. L. (2010) · Blood · doi:10.1182/blood-2009-07-235176 · Cited by 111
Yamaguchi, M., Hirayama, F., Kanai, M., Sato, N., Fukazawa, K., Yamashita, K., Sawada, K., Koike, T., Kuwabara, M., Ikeda, H., et al. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(00)00653-6 · Cited by 63
Chung, Y. S., Kim, H. J., Kim, T.-M., Hong, S.-H., Kwon, K.-R., An, S., Park, J.-H., Lee, S., & Oh, I.-H. (2009) · Blood · doi:10.1182/blood-2009-01-197780 · Cited by 43 · cited 4×
“We tested the hypothesis that the epigenetically malleable genome of hematopoietic stem-progenitors [13–17] can be fully activated by extrinsic signals from their microenvironmental niche [39–41].”
BackgroundInfluentialTaylor, T. M., Kim, Y., Ou, X., Derbigny, W. A., & Broxmeyer, H. E. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0484 · Cited by 38
Koh, S. H., Choi, H. S., Park, E. S., Kang, H. J., Ahn, H. S., & Shin, H. Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.077 · Cited by 27
Hasegawa, Y., Takahashi, N., Forrest, A. R. R., Shin, J. W., Kinoshita, Y., Suzuki, H., & Hayashizaki, Y. (2011) · Stem Cells · doi:10.1002/stem.673 · Cited by 22
Human Embryonic and Induced Pluripotent Stem Cells: Lineage-Specific Differentiation Protocols
(2011) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-61779-267-0 · Cited by 18
Hyperdynamic Plasticity of Chromatin Proteins in Pluripotent Embryonic Stem Cells
Meshorer, E., Yellajoshyula, D., George, E. M., Scambler, P. J., Brown, D. T., & Misteli, T. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.12.005 · Cited by 13
Peters, A., & Zambidis, E. T. (2011) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-61779-267-0_16 · Cited by 6
Self-citation
Cited by
Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs
Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L.-H., Peters, A., Park, T. S., Zambidis, E. T., Meyer, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5047 · Cited by 970
Self-citationAdvances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09935-x · Cited by 519
A comparison of non-integrating reprogramming methods
Schlaeger, T. M., Daheron, L., Brickler, T. R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3070 · Cited by 510
Effects of Diabetes on the Eye
Lutty, G. A. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12979 · Cited by 233
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
Self-citation
Metadata
- Authors
- Park, T. S., Huo, J. S., Peters, A., Talbot, C. C., Verma, K., Zimmerlin, L., Kaplan, I. M., & Zambidis, E. T.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Zambidis, Elias T.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-08
- Volume
- 7
- Issue
- 8
- Pages
- e42838
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3414503
- OpenAlex
- W2083049786
- Cited by
- 45
- References
- 59
- Citations by year
- 2023: 1 · 2021: 7 · 2020: 9 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 8 · 2013: 4
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Maryland Stem Cell Research Fund (2007-MSCRF II-0379-00)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (U01HL100397, R03HL096220, U01HL099775, K08HL077595)
- National Cancer Institute (CA 60441, T32CA060441)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, non-integrating reprogramming, myeloid progenitor cells, umbilical cord blood, hematopoietic growth factors, Nanog, Yamanaka factors, hematopoietic stem cells, transcriptional circuits, induced pluripotency
- MeSH terms
- Animals, Cell Separation, Fibroblasts, Flow Cytometry, Hematopoietic Stem Cells, Humans, Stem Cells, Signal Transduction, Keratinocytes, NF-kappa B, Leukocyte Common Antigens, Coculture Techniques, Antigens, CD34, Cell Lineage, Computational Biology, Myeloid Cells, Intercellular Signaling Peptides and Proteins, Mice, Induced Pluripotent Stem Cells, Sialic Acid Binding Ig-like Lectin 3, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.